GLAXOSMITHKLINE RESEARCH & DEVELOPMENT LIMITED
Other research and experimental development on natural sciences and engineering
GLAXOSMITHKLINE RESEARCH & DEVELOPMENT LIMITED
Other research and experimental development on natural sciences and engineering
AI Analysis
AI Analysis
Analyze director networks, ownership patterns, and company connections
Sign in to access AI-powered company analysis
Sign InCompanyTrack AI can make mistakes. Check important info.
Contact & Details
Contact
Update DetailsRegistered Address
79 New Oxford Street London WC1A 1DG United Kingdom
Office (Ware)
45 Priory St, Ware SG12 0DE
Office (Brentford, Middlesex, United Kingdom)
980 Great West Road, TW8 9GS
Telephone
+302106882100Website
gsk.comCredit Report
Discover GLAXOSMITHKLINE RESEARCH & DEVELOPMENT LIMITED's Credit Score, limit, and payment likelihood.
Mutual Companies
Financials
Financials
Net Assets, Total Assets & Total Liabilities (2014–2023)
Cash in Bank
N/A
Net Assets
£1190.38M
Total Liabilities
£989.10M
Turnover
£1450.45M
Employees
3328
Debt Ratio
45%
Financial History
Revenue, profit, EBITDA and key financial figures
2023 Dec Year End | 2022 Dec Year End | |
|---|---|---|
| P&L | ||
| Revenue | ||
| Gross Profit | ||
| Operating Profit | ||
| Net Profit | ||
| EBITDA | ||
| Assets | ||
| Cash | ||
| Total Assets | ||
| Liabilities | ||
| Total Liabilities | ||
| Key Metrics | ||
| Employees | ||
Unlock 10 years of financial data
Sign up to view revenue, profit, assets and more
Funding
Fundraising & Grants
No fundraising or grants recorded
Investors (0)
No investor information available
Officers
Officers
| Status | ||
|---|---|---|
| Aidan Lynch | Director | Active |
| Christopher David George Pickering | Director | Active |
| Demet Gurunlu Russ | Director | Active |
| Edinburgh Pharmaceutical Industries Limited | Corporate-director | Active |
| Glaxo Group Limited | Corporate-director | Active |
| Graham Paul Rivers | Director | Active |
| Kaivan Khavandi | Director | Active |
| Victoria Whyte | Secretary | Active |
Persons with Significant Control
Persons with Significant Control (1)
Glaxo Group Limited
United Kingdom
- Ownership Of Shares 75 To 100 Percent
- Voting Rights 75 To 100 Percent
- Right To Appoint And Remove Directors
Group Structure
Group Structure
Charges
Charges
Documents
Company Filings
| Date | Category | Description | Document |
|---|---|---|---|
| 14 Aug 2025 | Accounts | Annual accounts made up to 2024-12-31 | View(30 pages) |
| 30 Jul 2025 | Confirmation Statement | Confirmation statement made on 2025-07-30 with no updates | View(3 pages) |
| 24 Sept 2024 | Officers | Change Person Secretary Company With Change Date | View(1 page) |
| 23 Sept 2024 | Officers | Change to director Mr Christopher David George Pickering on 2024-09-11 | View(2 pages) |
| 23 Sept 2024 | Officers | Change to director Dr Kaivan Khavandi on 2024-09-11 | View(2 pages) |
Confirmation statement made on 2025-07-30 with no updates
Change to director Mr Christopher David George Pickering on 2024-09-11
Recent Activity
Latest Activity
Annual accounts made up to 2024-12-31
6 months ago on 14 Aug 2025
Confirmation statement made on 2025-07-30 with no updates
6 months ago on 30 Jul 2025
Change Person Secretary Company With Change Date
1 years ago on 24 Sept 2024
Change to director Mr Christopher David George Pickering on 2024-09-11
1 years ago on 23 Sept 2024
Change to director Dr Kaivan Khavandi on 2024-09-11
1 years ago on 23 Sept 2024